XWPharma is harnessing clinically validated mechanisms of action to develop novel drug candidates with optimized pharmacokinetics, resulting in superior therapies for the treatment of common, debilitating neurological diseases.
XWPharma is a biopharmaceutical company dedicated to the discovery and development of potential first- and best-in-class medicines with unique features to address the medical needs of patients suffering from debilitating neurological diseases. The company, which has offices in theUnited States, China, and Taiwan, has created novel therapies that leverage mechanisms
